Resultados de búsqueda - Heinz Leibl

  • Mostrando 1 - 7 Resultados de 7
Limitar resultados
  1. 1
    Human Epidermal Cells Synthesize HLA-DR Alloantigens In Vitro upon Stimulation with γ-Interferon

    Human Epidermal Cells Synthesize HLA-DR Alloantigens In Vitro upon Stimulation with γ-Interferon por Beatrix Volc‐Platzer, Heinz Leibl, Thomas A. Luger, Gabriele Zahn, Georg Stingl

    Publicado 1985
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Expression of Thy-1 Antigen by Murine Epidermal Cells

    Expression of Thy-1 Antigen by Murine Epidermal Cells por Erwin Tschachler, Gerold Schuler, J. Hutterer, Heinz Leibl, Klaus Wolff, Georg Stingl

    Publicado 1983
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies

    Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies por Rolf Gustafson, Ann Gardulf, Susanne V. Hansen, Heinz Leibl, Werner Engl, Magdalena Lindén, Anne Müller, Lennart Hammarström

    Publicado 2008
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies

    Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies por Michael Borte, G. Kriván, Beáta Dérfalvi, László Maródi, Thomas Harrer, Stephen Jolles, Christelle Bourgeois, Werner Engl, Heinz Leibl, Barbara McCoy, David Gelmont, Leman Yel

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency

    Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency por Richard L. Wasserman, Isaac Melamed, Mark R. Stein, Sudhir Gupta, Jennifer M. Puck, Werner Engl, Heinz Leibl, Barbara McCoy, Victoria Empson, David Gelmont, Richard I. Schiff

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America

    Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America por Daniel Suez, Mark R. Stein, Sudhir Gupta, Iftikhar Hussaın, Isaac Melamed, Kenneth Paris, Amy Darter, Christelle Bourgeois, Sandor Fritsch, Heinz Leibl, Barbara McCoy, David Gelmont, Leman Yel

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency

    Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency por Richard L. Wasserman, Isaac Melamed, Mark R. Stein, Werner Engl, Marlies Sharkhawy, Heinz Leibl, Jennifer M. Puck, Arye Rubinstein, Lisa Kobrynski, Sudhir Gupta, Andrew J. Grant, Anoshie Ratnayake, Wendell Richmond, Joseph A. Church, Leman Yel, David Gelmont

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: